Palliative care is broadly recognized as an essential treatment model for providing effective, comprehensive, and transdisciplinary care for those with progressive, lifelimiting illnesses (1) . Dementia has been increasingly recognized as one of these illnesses, and indeed a life-altering illness for families and a life-limiting illness for patients (2) . The interface of psychiatry and palliative care also has been increasing recognized as important for providing the best whole-person, patient/family centered care (3, 4) . The article by Lee et al. in this issue touches briefly on a few of the important topics to consider when taking a palliative care approach to dementia care.
We hope to expand upon some of what was covered by Lee et al and point readers to resources for further improving their approach to patients with dementia.
To begin, the management of neuropsychiatric symptoms is a challenging, very briefly touched on in this review, with the literature plagued by 1) heterogeneity in terminology and focus (neuropsychiatric symptoms, behavioral and psychological symptoms of dementia (BPSD), and symptoms of agitation, aggression, apathy, anxiety, etc.); 2) heterogeneity in measures; 3) studies of limited size or quality; and 4) a conflicting or weak evidence base (5). Yet, there are guiding principles, based on existing evidence, guidelines, and expert opinion, that may help in managing neuropsychiatric symptoms, which would be helpful to add. Many approaches and algorithms exist, DICE (Describe, Investigate, Create, Evaluate) (5) is one, but having and using a standardized approach may be more important than debating the merits of any one of these. -Considering delirium if symptoms are new, and if there is an acute change, where the provider should investigate for underlying, reversible, medical conditions.
-Categorizing behavior and symptoms, searching for precipitants, and attempting to manage non-pharmacologically when not severe or risking the safety of patients or others.
-Becoming familiar with programs that may reduce the occurrence or severity of neuropsychiatric symptoms, such as PREVENT (6) or communication/interaction training programs for caregivers and staff through many organizations including local chapters of the Alzheimer's Association.
-Considering other non-pharmacological interventions; while less proven in trials, individual patients may respond to music therapy, aromatherapy, and other integrative medicine approaches.
-When psychoactive medications are needed because of persistent or severe symptoms, be clear with the patient and family about the symptom being targeted (e.g., delusions, hallucinations, anxiety, etc.) and how they and you will judge if the medication is working. Set realistic goals, educate about potential side effects to watch for and their absolute (as opposed to relative risk), and have a plan for Page 3 of 7 frequent communication -by phone in between office visits may work well in some cases -to judge response to medication and titrate or change treatments (7).
-Understanding how different care settings, such as nursing homes, bring their own opportunities and challenges, including staff issues, work flow, and anti-psychotic use policies, with dementia being a target of a nation-wide program to reduce usage.
-Providing assistance to family and caregivers who often are severely stressed and in need of support and services. Practices need to be able to refer caregivers to helpful resources like the local chapter of the Alzheimer's Association, local Area Agency on Aging, and other community organizations. There is also the potential to facilitate mental health services for caregivers given the prevalence of stress/burnout, depression, and sleep disturbances in these individuals. 
